In the latest episode of The Driver’s Seat, Henry Catchpole reviews the new Porsche 911 GT3—the 992.2 generation if you like your model numbers. Donning his finest James Hoffmann T-shirt, Catchpole ...

No additional power thanks to emissions limitations, but sharper reactions and more comfortable.

Aston Martin has, thanks to former CEO and now non-exec chairman Dr. Ulrich Bez, real motorsport currency. It vies with Audi, BMW, Mercedes and Porsche in challenging for GT racing honours, and runs ...

Trackhouse Racing and TF Sport will collaborate to field the No. 91 Corvette Z06 GT3.R at the 2025 Daytona 24 Hours. When it was first announced, a rendering of the Daytona-bound race car was clad ...

Manthey Kits are also available for other Porsche models. The U.S. offerings include kits for the 991-generation 911 GT3 RS, the 992-generation 911 GT3, and the 718 Cayman GT4 RS. Manthey has also ...

Despite middling box office returns deep into its theatrical run, Gladiator 2 has still become one of the top 30 highest-grossing R-rated movies ever at the worldwide box office at the time of ...

Porsche’s 992.2-generation 911 model has grown beyond the initial GTS hybrid to include the Carrera S once again. The every-person Porsche model is available to order now. What you get for your ...

Both the Porsche and Ferrari have around 1,000 hp, but the EV has the added advantage of instant torque. The Taycan Turbo GT and SF90 Stradale are very well matched when launching off the line.

Led by Paul Mescal, Gladiator II follows Lucius, who is forced to enter the infamous Colosseum after his home is conquered by the emperors who now lead Rome. Mescal is joined by an all-star ...

He was instantly smitten. Dickinson turned that passion into a multi-million dollar business, reimagining classic Porsche models with his own twist. To be perfectly clear, Singer is not sponsored ...

Some cars, however, eventually start to appreciate in value, and the Porsche 911 GT3 RS you see here is a prime example of just how much a car can appreciate over time.

Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...